https://orcid.org/0000-0002-8491-5704
Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Andreas Schneider, Reto Jost, Christoph Jordi & Jakob Lange. (2023) Autoinjectors for large-volume subcutaneous drug delivery: a review of current research and future directions. Expert Opinion on Drug Delivery 20:6, pages 815-830.
Read now
Read now
Andreas Schneider, Harald Kolrep, Hanns-Peter Horn, Christoph Jordi, Sina Gierig & Jakob Lange. (2023) Understanding patient preferences for handheld autoinjectors versus wearable large-volume injectors. Expert Opinion on Drug Delivery 20:2, pages 273-283.
Read now
Read now
Jane Loftus, Yong Chen, Anu Gupta, Michael P. Wajnrajch, Jose Ma. J. Alvir, Lawrence A. Silverman, Priti Jhingran, Mahesh Kumar & Sapna Prasad. (2022) Suboptimal adherence to prescribed daily growth hormone regimen among medicaid beneficiaries in the United States. Current Medical Research and Opinion 38:6, pages 917-925.
Read now
Read now
Jane Loftus, Yong Chen, Jose Ma. J. Alvir, Lei Chi, Shibasish Dasgupta, Anu Gupta & Michael P. Wajnrajch. (2021) Suboptimal adherence to daily growth hormone in a US real-world study: an unmet need in the treatment of pediatric growth hormone deficiency. Current Medical Research and Opinion 37:12, pages 2141-2150.
Read now
Read now
Articles from other publishers (13)
Jelena Belic, Theresa Zekoll, Stefan Riedl & Manfred Windisch. (2023) Wie werden langwirksame Wachstumshormonpräparate in Österreich von Ärzt*innen und Patienteneltern wahrgenommen?Perceptions of Long-Acting Growth Hormone Preparations by Physicians and Patients in Austria. Pädiatrie & Pädologie.
Crossref
Crossref
Zvi Zadik, Nataliya Zelinska, Violeta Iotova, Yulia Skorodok, Oleg Malievsky, Nelly Mauras, Srinivas Rao Valluri, Aleksandra Pastrak & Ron Rosenfeld. (2023) An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment. Journal of Pediatric Endocrinology and Metabolism 36:3, pages 261-269.
Crossref
Crossref
Luis A. Villarruel, Belén Brie, Sofía Municoy, Damasia Becú-Villalobos, Martín F. Desimone & Paolo N. Catalano. (2023) Silica-collagen nanoformulations with extended human growth hormone release. International Journal of Pharmaceutics 634, pages 122662.
Crossref
Crossref
Margaret Steiner, Jacklyn Frank & Paul Saenger. (2023) Long‐acting growth hormone in 2022. Pediatric Investigation 7:1, pages 36-42.
Crossref
Crossref
Jane Loftus, Andrew Yaworsky, Carl L. Roland, Diane Turner-Bowker, Megan McLafferty, Sylvia Su & Roger E. Lamoureux. (2022) Experience of switching from a daily to a less frequent administration of injection treatments. PLOS ONE 17:11, pages e0278293.
Crossref
Crossref
Bita Taghizadeh, Mahmoud Reza Jaafari & Nosratollah Zarghami. (2022) New insight into the importance of formulation variables on parenteral growth hormone preparations: potential effect on the injection-site pain. Frontiers in Endocrinology 13.
Crossref
Crossref
Aristides K Maniatis, Mauri Carakushansky, Sonya Galcheva, Gnanagurudasan Prakasam, Larry A Fox, Adriana Dankovcikova, Jane Loftus, Andrew A Palladino, Maria de los Angeles Resa, Carrie Turich Taylor, Mehul T Dattani & Jan Lebl. (2022) Treatment Burden of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Randomized Study. Journal of the Endocrine Society 6:10.
Crossref
Crossref
Margaret A. Chang, Audrey Kapre, Derrick Kaufman, David R. Kardatzke, Melvin Rabena, Shienal Patel, Ashwini Bobbala, Shamika Gune, Anne Fung & Gene Wallenstein. (2022) Patient Preference and Treatment Satisfaction With a Port Delivery System for Ranibizumab vs Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration. JAMA Ophthalmology 140:8, pages 771.
Crossref
Crossref
Cheri L Deal, Joel Steelman, Elpis Vlachopapadopoulou, Renata Stawerska, Lawrence A Silverman, Moshe Phillip, Ho-Seong Kim, CheolWoo Ko, Oleg Malievskiy, Jose F Cara, Carl L Roland, Carrie Turich Taylor, Srinivas Rao Valluri, Michael P Wajnrajch, Aleksandra Pastrak & Bradley S Miller. (2022) Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study. The Journal of Clinical Endocrinology & Metabolism 107:7, pages e2717-e2728.
Crossref
Crossref
B. Jouret & M. Tauber. (2022) Relationship between adherence to growth hormone therapy and growth. Archives de Pédiatrie 28:8, pages 28/8S9-28/8S13.
Crossref
Crossref
Hiroshi Nishioka & Akira Shimatsu. (2022) Adult Growth Hormone Deficiency : A Practical Approach to Diagnosis and Treatment for Neurosurgeons成人成長ホルモン分泌不全症. Japanese Journal of Neurosurgery 31:5, pages 313-322.
Crossref
Crossref
Christine Michaels-Igbokwe, Gillian R. Currie, Bryanne L. Kennedy, Karen V. MacDonald & Deborah A. Marshall. (2021) Methods for Conducting Stated Preference Research with Children and Adolescents in Health: A Scoping Review of the Application of Discrete Choice Experiments. The Patient - Patient-Centered Outcomes Research 14:6, pages 741-758.
Crossref
Crossref
Toshiaki Tanaka, Takahiro Sato, Akira Yuasa, Takeshi Akiyama & Adeeb Tawseef. (2021) Patient preferences for growth hormone treatment in Japanese children. Pediatrics International 63:10, pages 1185-1191.
Crossref
Crossref